Candel Therapeutics Drops 1.43%: BIO 2025 Impact?

miércoles, 4 de junio de 2025, 6:40 pm ET1 min de lectura
CADL--
Candel Therapeutics, Inc. declined 1.43% in after-hours trading, with the company announcing that its executives will be attending and participating in the upcoming BIO International Convention 2025, taking place June 16-19, 2025 in Boston. The company will engage in one-on-one meetings with investors and potential partners to provide key updates on its strategic direction and clinical development of its lead asset, tecarfarin.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios